Rhonda B. Levin

1.4k total citations
9 papers, 1.1k citations indexed

About

Rhonda B. Levin is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Rhonda B. Levin has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Organic Chemistry. Recurrent topics in Rhonda B. Levin's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (2 papers). Rhonda B. Levin is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (2 papers). Rhonda B. Levin collaborates with scholars based in United States. Rhonda B. Levin's co-authors include Bruce D. Dorsey, Joseph P. Vacca, Stacey L. McDaniel, William A. Schleif, Joan A. Zugay, J C Quintero, E. Jill Roth, Emilio A. Emini, James P. Guare and M. Katharine Holloway and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Rhonda B. Levin

9 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Rhonda B. Levin	527	428	425	405	159	9	1.1k
Sally Redshaw	715 1.4×	503 1.2×	376 0.9×	594 1.5×	162 1.0×	26	1.3k
Stacey L. McDaniel	447 0.8×	289 0.7×	365 0.9×	369 0.9×	72 0.5×	7	863
Marlene M. Rayner	597 1.1×	590 1.4×	527 1.2×	533 1.3×	214 1.3×	19	1.3k
Antonin Kröhn	647 1.2×	461 1.1×	307 0.7×	540 1.3×	118 0.7×	9	1.1k
Norman E. Wideburg	888 1.7×	613 1.4×	603 1.4×	710 1.8×	123 0.8×	29	1.5k
K. E. B. PARKES	640 1.2×	632 1.5×	400 0.9×	513 1.3×	122 0.8×	32	1.4k
James P. Guare	432 0.8×	425 1.0×	546 1.3×	369 0.9×	67 0.4×	32	1.1k
Bhasker V. Shetty	476 0.9×	315 0.7×	327 0.8×	346 0.9×	92 0.6×	28	1.1k
M.N.L. Nalam	689 1.3×	658 1.5×	208 0.5×	577 1.4×	222 1.4×	21	1.3k
Tsutomu Mimoto	475 0.9×	427 1.0×	325 0.8×	388 1.0×	129 0.8×	20	878

Countries citing papers authored by Rhonda B. Levin

Since Specialization

Citations

This map shows the geographic impact of Rhonda B. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda B. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda B. Levin more than expected).

Fields of papers citing papers by Rhonda B. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhonda B. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda B. Levin. The network helps show where Rhonda B. Levin may publish in the future.

Co-authorship network of co-authors of Rhonda B. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Rhonda B. Levin. A scholar is included among the top collaborators of Rhonda B. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhonda B. Levin. Rhonda B. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Perni, Robert B., J. PITLIK, John J. Court, et al.. (2004). Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization. Bioorganic & Medicinal Chemistry Letters. 14(6). 1441–1446. 41 indexed citations

Perni, Robert B., Lawrence F. Courtney, David D. Deininger, et al.. (2003). Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants. Bioorganic & Medicinal Chemistry Letters. 13(22). 4059–4063. 25 indexed citations

Dorsey, Bruce D., Colleen M. McDonough, Stacey L. McDaniel, et al.. (2000). Identification of MK-944a: A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors. Journal of Medicinal Chemistry. 43(18). 3386–3399. 41 indexed citations

Holloway, M. Katharine, Jenny Wai, Thomas A. Halgren, et al.. (1995). A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. Journal of Medicinal Chemistry. 38(2). 305–317. 178 indexed citations

Hungate, Randall W., Joseph P. Vacca, Stacey L. McDaniel, et al.. (1994). Synthesis, antiviral activity, and bioavailability studies of γ-lactam derived HIV protease inhibitors. Bioorganic & Medicinal Chemistry. 2(9). 859–879. 16 indexed citations

Dorsey, Bruce D., Rhonda B. Levin, Stacey L. McDaniel, et al.. (1994). L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor. Journal of Medicinal Chemistry. 37(21). 3443–3451. 324 indexed citations

Vacca, Joseph P., Bruce D. Dorsey, William A. Schleif, et al.. (1994). L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.. Proceedings of the National Academy of Sciences. 91(9). 4096–4100. 420 indexed citations

Dorsey, Bruce D., Stacey L. McDaniel, Rhonda B. Levin, et al.. (1994). Synthesis and evaluation of pyridyl analogs of L-735,524: Potent HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 4(23). 2769–2774. 13 indexed citations

HOFFMAN, J. M., et al.. (1992). Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phthalimidoalkyl and -alkylamino analogs. Journal of Medicinal Chemistry. 35(21). 3784–3791. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact